Genetic Analysis is active in medical technology. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-
-0.6
%
-6,82%
Latest
8.2
High
8.78
Low
7.88
Volume
230 062
Turnover (NOK)
1 871 725
Value (MNOK)
204,3

Board

CEO

  • Ronny Hermansen

Chairperson of the Board

  • Kathryn Baker

Board

  • Ashok Shah
  • Camilla Huse Bondesson
  • Rune Sørum
  • Staffan Strömberg

Upcoming reports

  • 2022-02-18 Bokslutskommuniké 2021